CVS Health (CVS) revenue and earnings history
CVS Health reported revenue of $402B for fiscal 2025 (year ended Dec 31, 2025), +7.8% on the year before, and net income of $1.77B.
Over 18 years, from fiscal 2007 to fiscal 2025, revenue grew at a compound rate of +9.7% a year.
Revenue and net income, 19 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $402B+7.8% | $4.66B | $1.77B | $10.6B | $2.83B | $7.81B | $535M | $0 | $3.4B | $8.45B | $60.5B | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: CVS Health (CVS) on OQRO.
Common questions
What was CVS Health's revenue in fiscal 2025?
$402B for the year ended Dec 31, 2025, as reported in its 10-K filed Feb 10, 2026. That is +7.8% on fiscal 2024 ($373B).
How fast has CVS Health's revenue grown?
From $76.3B in fiscal 2007 to $402B in fiscal 2025: a compound annual growth rate of +9.7% over 18 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure CVS Health tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
